The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
MRP3, an organic anion transporter able to transport anti-cancer drugs
Open accessAbstract
The human multidrug-resistance protein ( MRP ) gene family contains at least six members: MRP1 , encoding the multidrug-resistance protein; MRP2 or cMOAT , encoding the canalicular multispecific organic anion transporter; and four homologs, called MRP3 , MRP4 , MRP5 , and MRP6 . In this report, we characterize MRP3, the closest homolog of MRP1. Cell lines were retrovirally transduced with MRP3 cDNA, and new monoclonal antibodies specific for MRP3 were generated. We show that MRP3 is an organic anion and multidrug transporter, like the GS-X pumps MRP1 and MRP2. In Madin–Darby canine kidney II cells, MRP3 routes to the basolateral membrane and mediates transport of the organic anion S -(2,4-dinitrophenyl-)glutathione toward the basolateral side of the monolayer. In ovarian carcinoma cells (2008), expression of MRP3 results in low-level resistance to the epipodophyllotoxins etoposide and teniposide. In short-term drug exposure experiments, MRP3 also confers high-level resistance to methotrexate. Neither 2008 cells nor Madin–Darby canine kidney II cells overexpressing MRP3 showed an increase in glutathione export or a decrease in the level of intracellular glutathione, in contrast to cells overexpressing MRP1 or MRP2 . We discuss the possible function of MRP3 in (hepatic) physiology and its potential contribution to drug resistance of cancer cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A comprehensive set of sequence analysis programs for the VAX
Devereux, J., Haeberli, P., & Smithies, O. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.1part1.387 · Cited by 14,222
Tietze, F. (1969) · Analytical Biochemistry · doi:10.1016/0003-2697(69)90064-5 · Cited by 6,047
An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs
Kozak, M. (1987) · Nucleic Acids Research · doi:10.1093/nar/15.20.8125 · Cited by 5,087
Kool, M., de Haas, M., Scheffer, G. L., Scheper, R. J., van Eijk, M. J., Juijn, J. A., Baas, F., & Borst, P. (1997) · PubMed · Cited by 882
Self-citationLeier, I., Jedlitschky, G., Buchholz, U., Cole, S. P., Deeley, R. G., & Keppler, D. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)46856-1 · Cited by 853
Congenital Jaundice in Rats with a Mutation in a Multidrug Resistance-Associated Protein Gene
Paulusma, C. C., Bosma, P. J., Zaman, G. J. R., Bakker, C. T. M., Otter, M., Scheffer, G. L., Scheper, R. J., Borst, P., & Elferink, R. P. J. O. (1996) · Science · doi:10.1126/science.271.5252.1126 · Cited by 822
Self-citationMutations in the MDR 3 gene cause progressive familial intrahepatic cholestasis
de Vree, J. M. L., Jacquemin, E., Sturm, E., Cresteil, D., Bosma, P. J., Aten, J., Deleuze, J.-F., Desrochers, M., Burdelski, M., Bernard, O., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.1.282 · Cited by 735
Self-citationThe human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump.
Zaman, G. J., Flens, M. J., van Leusden, M. R., de Haas, M., Mülder, H. S., Lankelma, J., Pinedo, H. M., Scheper, R. J., Baas, F., & Broxterman, H. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.19.8822 · Cited by 680
Self-citationThe ATP-dependent glutathione S-conjugate export pump
Ishikawa, T. (1992) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(92)90489-v · Cited by 654
Evers, R., Kool, M., van Deemter, L., Janssen, H., Calafat, J., Oomen, L. C., Paulusma, C. C., Oude Elferink, R. P., Baas, F., Schinkel, A. H., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci119886 · Cited by 620
Self-citation
Cited by
Multidrug resistance in cancer: role of ATP–dependent transporters
Gottesman, M. M., Fojo, T., & Bates, S. E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc706 · Cited by 5,536
Targeting multidrug resistance in cancer
Szakács, G., Paterson, J. K., Ludwig, J. A., Booth-Genthe, C., & Gottesman, M. M. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1984 · Cited by 3,609
Mechanisms of Cancer Drug Resistance
Gottesman, M. M. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.103929 · Cited by 2,643
A family of drug transporters: the multidrug resistance-associated proteins
Borst, P., Evers, R., Kool, M., & Wijnholds, J. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.16.1295 · Cited by 1,751
Self-citationThe Human ATP-Binding Cassette (ABC) Transporter Superfamily
Dean, M., Rzhetsky, A., & Allikmets, R. (2001) · Genome Research · doi:10.1101/gr.184901 · Cited by 1,748
Mammalian ABC Transporters in Health and Disease
Borst, P., & Elferink, R. O. (2002) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.71.102301.093055 · Cited by 1,571
Self-citationMammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview
Schinkel, A. H., & Jonker, J. W. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00169-2 · Cited by 1,386
Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview
Schinkel, A. H., & Jonker, J. W. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.027 · Cited by 1,231
P-glycoprotein: from genomics to mechanism
Ambudkar, S. V., Kimchi-Sarfaty, C., Sauna, Z. E., & Gottesman, M. M. (2003) · Oncogene · doi:10.1038/sj.onc.1206948 · Cited by 1,074
Bile salt transporters: molecular characterization, function, and regulation
Trauner, M., & Boyer, J. L. (2003) · Physiological Reviews · doi:10.1152/physrev.00027.2002 · Cited by 999
Overview of resistance to systemic therapy in patients with breast cancer
Gonzalez-Angulo, A. M., Morales-Vasquez, F., & Hortobagyi, G. N. (2007) · Advances in Experimental Medicine and Biology · doi:10.1007/978-0-387-74039-3_1 · Cited by 904
Xenobiotic, Bile Acid, and Cholesterol Transporters: Function and Regulation
Klaassen, C. D., & Aleksunes, L. M. (2010) · Pharmacological Reviews · doi:10.1124/pr.109.002014 · Cited by 807
König, J., Nies, A. T., Cui, Y., Leier, I., & Keppler, D. (1999) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(99)00169-8 · Cited by 791
Deeley, R. G., Westlake, C., & Cole, S. P. C. (2006) · Physiological Reviews · doi:10.1152/physrev.00035.2005 · Cited by 761
“As indicated above, MRP3 is a very poor transporter of GS-conjugates and does not transport GSH, which may explain its inability to confer resistance to other classes of natural product type drugs (252).”
BackgroundInfluentialLitman, T., Druley, T. E., Stein, W. D., & Bates, S. E. (2001) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000912 · Cited by 688
Enterohepatic Circulation: Physiological, Pharmacokinetic and Clinical Implications
Roberts, M. S., Magnusson, B. M., Burczynski, F. J., & Weiss, M. (2002) · Clinical Pharmacokinetics · doi:10.2165/00003088-200241100-00005 · Cited by 664
Enterohepatic bile salt transporters in normal physiology and liver disease
Kullak-ublick, G. A., Stieger, B., & Meier, P. J. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.06.005 · Cited by 658
The multidrug resistance protein family
Borst, P., Evers, R., Kool, M., & Wijnholds, J. (1999) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(99)00167-4 · Cited by 648
Self-citationKönig, J., Cui, Y., Nies, A. T., & Keppler, D. (2000) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2000.278.1.g156 · Cited by 620
The MRP family of drug efflux pumps
Kruh, G. D., & Belinsky, M. G. (2003) · Oncogene · doi:10.1038/sj.onc.1206953 · Cited by 614
Meier, P. J., & Stieger, B. (2002) · Annual Review of Physiology · doi:10.1146/annurev.physiol.64.082201.100300 · Cited by 586
Chan, L. M. S., Lowes, S., & Hirst, B. H. (2004) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2003.07.003 · Cited by 582
Banales, J. M., Huebert, R. C., Karlsen, T., Strazzabosco, M., LaRusso, N. F., & Gores, G. J. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0125-y · Cited by 517
Impact of Drug Transporter Studies on Drug Discovery and Development
Mizuno, N., Niwa, T., Yotsumoto, Y., & Sugiyama, Y. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.3.1 · Cited by 490
Wijnholds, J., Mol, C. A. A. M., van Deemter, L., de Haas, M., Scheffer, G. L., Baas, F., Beijnen, J. H., Scheper, R. J., Hatse, S., De Clercq, E., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.120159197 · Cited by 478
Self-citationCellular and molecular aspects of drug transport in the kidney
Inui, K.-I., Masuda, S., & Saito, H. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00251.x · Cited by 450
Taipalensuu, J., Törnblom, H., Lindberg, G., Einarsson, C., Sjöqvist, F., Melhus, H., Garberg, P., Sjöström, B., Lundgren, B., & Artursson, P. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29314-9 · Cited by 444
Choudhuri, S., & Klaassen, C. D. (2006) · International Journal of Toxicology · doi:10.1080/10915810600746023 · Cited by 415
The apical conjugate efflux pump ABCC2 (MRP2)
Nies, A. T., & Keppler, D. (2007) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-006-0109-y · Cited by 398
Transport of Cyclic Nucleotides and Estradiol 17-β-d-Glucuronide by Multidrug Resistance Protein 4
Chen, Z.-S., Lee, K., & Kruh, G. D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104833200 · Cited by 396
Matherly, L. H., & Goldman, I. D. (2003) · Vitamins & Hormones · doi:10.1016/s0083-6729(03)01012-4 · Cited by 386
Toxicological relevance of the multidrug resistance protein 1, MRP1 (ABCC1) and related transporters
Leslie, E. (2001) · Toxicology · doi:10.1016/s0300-483x(01)00454-1 · Cited by 376
Resistance mechanisms associated with altered intracellular distribution of anticancer agents
Larsen, A. K., Escargueil, A. E., & Skladanowski, A. (2000) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00073-x · Cited by 369
Zollner, G. (2001) · Hepatology · doi:10.1053/jhep.2001.22646 · Cited by 362
Mechanisms and strategies to overcome chemotherapy resistance in metastatic breast cancer
Coley, H. M. (2008) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2008.01.007 · Cited by 351
Molecular basis of antifolate resistance
Assaraf, Y. G. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9049-z · Cited by 338
ATP-dependent Transport of Bile Salts by Rat Multidrug Resistance-associated Protein 3 (Mrp3)
Hirohashi, T., Suzuki, H., Takikawa, H., & Sugiyama, Y. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.4.2905 · Cited by 338
Chemotherapy-induced resistance by ATP-binding cassette transporter genes
GILLET, J., EFFERTH, T., & REMACLE, J. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2007.05.002 · Cited by 337
Zollner, G., Marschall, H.-U., Wagner, M., & Trauner, M. (2006) · Molecular Pharmaceutics · doi:10.1021/mp060010s · Cited by 335
Gene Expression Patterns in Ovarian Carcinomas
Schaner, M. E., Ross, D. T., Ciaravino, G., Sørlie, T., Troyanskaya, O., Diehn, M., Wang, Y. C., Duran, G. E., Sikic, T. L., Caldeira, S., et al. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-05-0279 · Cited by 327
Expression of members of the multidrug resistance protein family in human term placenta
St-Pierre, M. V., Serrano, M. A., Macias, R. I. R., Dubs, U., Hoechli, M., Lauper, U., Meier, P. J., & Marin, J. J. G. (2000) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.2000.279.4.r1495 · Cited by 325
Multidrug Resistance Proteins (MRPs, ABCCs): Importance for Pathophysiology and Drug Therapy
Keppler, D. (2011) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-14541-4_8 · Cited by 318
Maher, J. M., Dieter, M. Z., Aleksunes, L. M., Slitt, A. L., Guo, G., Tanaka, Y., Scheffer, G. L., Chan, J. Y., Manautou, J. E., Chen, Y., et al. (2007) · Hepatology · doi:10.1002/hep.21831 · Cited by 315
Self-citationRecent development and prospects of surface modification and biomedical applications of MXenes
Huang, H., Jiang, R., Feng, Y., Ouyang, H., Zhou, N., Zhang, X., & Wei, Y. (2020) · Nanoscale · doi:10.1039/c9nr07616f · Cited by 313
ABC transporters in lipid transport
Borst, P., Zelcer, N., & van Helvoort, A. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(00)00053-6 · Cited by 300
Self-citationMultidrug resistance associated proteins in multidrug resistance
Sodani, K., Patel, A., Kathawala, R. J., & Chen, Z.-S. (2012) · Chinese Journal of Cancer · doi:10.5732/cjc.011.10329 · Cited by 300
Multidrug resistance-associated proteins 3, 4, and 5
Borst, P., de Wolf, C., & van de Wetering, K. (2007) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-006-0054-9 · Cited by 299
Self-citationABC-transporters: implications on drug resistance from microorganisms to human cancers
Lage, H. (2003) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(03)00203-6 · Cited by 298
Multidrug Resistance-Associated Proteins: Expression and Function in the Central Nervous System
Dallas, S., Miller, D. S., & Bendayan, R. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.2.3 · Cited by 296
Up–Regulation of Basolateral Multidrug Resistance Protein 3 (Mrp3) in Cholestatic Rat Liver
Donner, M. G., & Keppler, D. (2001) · Hepatology · doi:10.1053/jhep.2001.26213 · Cited by 292
Soroka, C. J., Lee, J. M., Azzaroli, F., & Boyer, J. L. (2001) · Hepatology · doi:10.1053/jhep.2001.23501 · Cited by 288
Membrane Transporters and Channels
Huang, Y., Anderle, P., Bussey, K. J., Barbacioru, C., Shankavaram, U., Dai, Z., Reinhold, W. C., Papp, A., Weinstein, J. N., & Sadée, W. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3884 · Cited by 285
Multidrug resistance proteins (MRPs/ABCCs) in cancer chemotherapy and genetic diseases
Chen, Z., & Tiwari, A. K. (2011) · The FEBS Journal · doi:10.1111/j.1742-4658.2011.08235.x · Cited by 274
Diestra, J. E., Scheffer, G. L., Català, I., Maliepaard, M., Schellens, J. H. M., Scheper, R. J., Germà‐Lluch, J. R., & Izquierdo, M. A. (2002) · The Journal of Pathology · doi:10.1002/path.1203 · Cited by 275
Self-citationKlein, M., Burla, B., & Martinoia, E. (2006) · FEBS Letters · doi:10.1016/j.febslet.2005.11.056 · Cited by 275
Riganti, C., Miraglia, E., Viarisio, D., Costamagna, C., Pescarmona, G., Ghigo, D., & Bosia, A. (2005) · Cancer Research · doi:10.1158/0008-5472.516.65.2 · Cited by 271
Bleasby, K., Castle, J. C., Roberts, C. J., Cheng, C., Bailey, W. J., Sina, J. F., Kulkarni, A. V., Hafey, M. J., Evers, R., Johnson, J. M., et al. (2006) · Xenobiotica · doi:10.1080/00498250600861751 · Cited by 269
Tissue Distribution and Induction of Human Multidrug Resistant Protein 3
Scheffer, G. L., Kool, M., de Haas, M., de Vree, J. M. L., Pijnenborg, A. C. L. M., Bosman, D. K., Oude Elferink, R. P. J., van der Valk, P., Borst, P., & Scheper, R. J. (2002) · Laboratory Investigation · doi:10.1038/labinvest.3780411 · Cited by 266
Self-citationCharacterization of Drug Transport by the Human Multidrug Resistance Protein 3 (ABCC3)
Zelcer, N., Saeki, T., Reid, G., Beijnen, J. H., & Borst, P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107041200 · Cited by 258
Self-citationZamek-Gliszczynski, M. J., Hoffmaster, K. A., Nezasa, K.-I., Tallman, M. N., & Brouwer, K. L. R. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.12.007 · Cited by 256
Characterization of inducible nature of MRP3 in rat liver
Ogawa, K., Suzuki, H., Hirohashi, T., Ishikawa, T., Meier, P. J., Hirose, K., Akizawa, T., Yoshioka, M., & Sugiyama, Y. (2000) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2000.278.3.g438 · Cited by 253
Zhao, R., & Goldman, I. D. (2003) · Oncogene · doi:10.1038/sj.onc.1206946 · Cited by 253
Minich, T., Riemer, J., Schulz, J. B., Wielinga, P., Wijnholds, J., & Dringen, R. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03737.x · Cited by 185
Apical/Basolateral Surface Expression of Drug Transporters and its Role in Vectorial Drug Transport
Ito, K., Suzuki, H., Horie, T., & Sugiyama, Y. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-6810-2 · Cited by 174
Boyer, J. L. (2013) · Comprehensive Physiology · doi:10.1002/j.2040-4603.2013.tb00519.x · Cited by 124
“In the presence of GSH, human MRP4 also has high affinity for glycine taurine conjugates and therefore may compete with BSEP export of bile salts under cholestatic conditions (454).”
Cheung, L., Flemming, C. L., Watt, F., Masada, N., Yu, D. M. T., Huynh, T., Conseil, G., Tivnan, A., Polinsky, A., Gudkov, A. V., et al. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.05.023 · Cited by 67
Tabibian, J. H., Masyuk, A. I., Masyuk, T. V., O'Hara, S. P., & LaRusso, N. F. (2013) · Comprehensive Physiology · doi:10.1002/j.2040-4603.2013.tb00495.x · Cited by 52
Wang, Y., Tu, M.-J., & Yu, A.-M. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1423416 · Cited by 21
Metadata
- Authors
- Kool, M., van der Linden, M., de Haas, M., Scheffer, G. L., de Vree, J. M. L., Smith, A. J., Jansen, G., Peters, G. J., Ponne, N., Scheper, R. J., Elferink, R. P. J. O., Baas, F., & Borst, P.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1999-06-08
- Volume
- 96
- Issue
- 12
- Pages
- 6914-6919
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2096204304
- Cited by
- 645
- References
- 49
- FWCI
- 22.14
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.